Your browser has 'Cookies' disabled, alert boxes will continue to appear without this feature.

RACGP Position statement: Medicinal use of cannabis products

RACGP Position statement: Medicinal use of cannabis products

Recent changes to legislation around medical cannabis and media coverage has created a perception of easy access to cannabis products. General practitioners may now experience greater patient demand to prescribe cannabis-based medications.

To address this, the RACGP has developed a position statement that outlines our position on prescribing medicinal cannabis products in general practice, the challenges GPs face, the current evidence and legal framework in Australia.

The current evidence-base for the use of cannabis-based medicines is still emerging, and the products can be prescribed under strict protocols. As for all medications, cannabis products must be approved or registered through the Therapeutic Goods Administration (TGA) before they can be prescribed. 

The Royal Australian College of General Practitioners Ltd

Contact Us

General Inquiries

General Enquiries

Opening hours 8:00 am-8:00 pm AEST

1800 4RACGP

1800 472 247 | +61 (3) 8699 0300 (international)

Payments

Payments

Pay invoices online

RACGP automated payment service: 1800 198 586

Follow us on

Follow RACGP on Twitter Follow RACGP on Facebook Follow RACGP on LinkedIn


Healthy Profession. Healthy Australia Logo

The Royal Australian College of General Practitioners Ltd (RACGP) ABN 34 000 223 807
RACGP House, 100 Wellington Parade, East Melbourne, Victoria 3002 Australia

Terms and conditions | Privacy statement
Sponsor conditions | Delegate conditions